Syphilis/Management of sexual partners

Page has default form::MedicalTherapy {{#meta: itemprop="medicalWebPageAudiences" content="patient"}}{{#meta: itemprop="medicalWebPageSpecialities" content="cardiology"}}{{#meta: itemprop="medicalWebPageInfoTypes" content="symptoms,diagnosis,treatment,causes,prognosis,complications"}}

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[4]

Sexually transmitted diseases Main Page
Syphilis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Syphilis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy Primary and Secondary Syphilis Latent Syphilis Tertiary Syphilis Neurosyphilis HIV-Infected Patients Pregnancy Management of Sexual Partners
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Syphilis/Management of sexual partners On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Syphilis/Management of sexual partners All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Syphilis/Management of sexual partners
CDC on Syphilis/Management of sexual partners
Syphilis/Management of sexual partners in the news
Blogs on Syphilis/Management of sexual partners
Directions to Hospitals Treating Syphilis
Risk calculators and risk factors for Syphilis/Management of sexual partners

Management of Sexual Partners

• Sexual transmission of Treponema pallidum is thought to occur only when mucocutaneous syphilitic lesions are present.

• Although such manifestations are uncommon after the first year of infection, persons exposed sexually to a patient who has syphilis in any stage should be evaluated clinically and serologically and treated with a recommended regimen, according to the following recommendations:

• Persons who were exposed within the 90 days preceding the diagnosis of primary, secondary, or early latent syphilis in a sex partner might be infected even if seronegative; therefore, such persons should be treated presumptively.

• Persons who were exposed more than 90 days before the diagnosis of primary, secondary, or early latent syphilis in a sex partner should be treated presumptively if serologic test results are not available immediately and the opportunity for follow-up is uncertain.

• For purposes of partner notification and presumptive treatment of exposed sex partners, patients with syphilis of unknown duration who have high nontreponemal serologic test titers (i.e., greater than 1:32) can be assumed to have early syphilis. For the purpose of determining a treatment regimen, however, serologic titers should not be used to differentiate early from late latent syphilis.

• Long-term sex partners of patients who have latent syphilis should be evaluated clinically and serologically for syphilis and treated on the basis of the evaluation findings.

• Sexual partners of infected patients should be considered at risk and provided treatment if they have had sexual contact with the patient within:

• 3 months plus the duration of symptoms for patients diagnosed with primary syphilis,
• 6 months plus duration of symptoms for those with secondary syphilis, and
• 1 year for patients with early latent syphilis.

References

Template:WikiDoc Sources

Related Pages

• Adverse Outcomes:
• Contraindications:
• Duplicate Therapies:
• Indications: {{:}}
• Prevents:
• Treats:Used To Treat::Syphilis